Saturday, July 01, 2023 2:49:27 PM
Dr. Pule is one of the authors.
Recent AUTL News
- Abstract for longer-term follow-up and additional data analysis of Pivotal Phase 2 FELIX study of obe-cel for adult r/r B-ALL selected for an oral presentation at ASCO • GlobeNewswire Inc. • 04/24/2024 02:00:00 PM
- Autolus Therapeutics to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024 • GlobeNewswire Inc. • 04/23/2024 11:00:00 AM
- Autolus Therapeutics announces acceptance of Marketing Authorization Application (MAA) by the European Medicines Agency (EMA) for obecabtagene autoleucel (obe-cel) for Patients with Relapsed/refractory (r/r) Adult B-Cell Acute Lymphoblastic Leukemia (B-ALL • GlobeNewswire Inc. • 04/02/2024 11:00:00 AM
- Autolus Therapeutics Announces Changes to its Board of Directors • GlobeNewswire Inc. • 04/01/2024 11:00:00 AM
- Autolus Therapeutics Reports Full Year 2023 Financial Results and Business Updates • GlobeNewswire Inc. • 03/14/2024 11:00:00 AM
- Autolus Therapeutics receives Medicines and Healthcare products Regulatory Agency (MHRA) certification for Nucleus commercial manufacturing site • GlobeNewswire Inc. • 03/12/2024 11:00:00 AM
- Autolus Therapeutics announces publication in Blood Cancer Journal • GlobeNewswire Inc. • 03/11/2024 11:00:00 AM
- Autolus Therapeutics to Report Full Year 2023 Financial Results and Business Updates on March 14, 2024 • GlobeNewswire Inc. • 02/29/2024 12:00:00 PM
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 02/23/2024 10:28:32 PM
- Autolus Therapeutics announces publication in Nature Communications • GlobeNewswire Inc. • 02/22/2024 12:00:00 PM
- Form SC 13D - General statement of acquisition of beneficial ownership • Edgar (US Regulatory) • 02/21/2024 10:01:33 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 01:37:20 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/09/2024 10:15:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/08/2024 09:17:55 PM
- Autolus Announces Pricing of Underwritten Offering • GlobeNewswire Inc. • 02/08/2024 12:00:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/08/2024 11:06:00 AM
- BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs • GlobeNewswire Inc. • 02/08/2024 10:45:00 AM
- Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers • Edgar (US Regulatory) • 02/08/2024 03:00:28 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/31/2024 09:10:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/26/2024 06:02:13 PM
- Autolus Therapeutics announces publication in ACS Chemical Biology • GlobeNewswire Inc. • 01/23/2024 12:00:00 PM
- Autolus Therapeutics Gets BLA Acceptance for Obecabtagene Autoleucel • Dow Jones News • 01/22/2024 12:54:00 PM
- Autolus Therapeutics announces acceptance of Biologics License Application for obecabtagene autoleucel (obe-cel) as a potential treatment for relapsed/refractory Adult B-cell Acute Lymphoblastic Leukemia (ALL) • GlobeNewswire Inc. • 01/22/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/10/2024 08:12:17 PM
- Autolus Therapeutics announces the appointment of Robert W. Azelby to its Board of Directors • GlobeNewswire Inc. • 01/10/2024 12:00:00 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM